NCT05880147

Brief Summary

This study aims to understand how well app-based consent performs compared to paper-based consent when recruiting families for a clinical research project. The investigators aim to demonstrate that app-based consent is as effective as traditional methods; this will be measured by questionnaires assessing the family's comprehension and preference.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 30, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

July 27, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 24, 2024

Completed
Last Updated

December 5, 2024

Status Verified

December 1, 2024

Enrollment Period

12 months

First QC Date

May 10, 2023

Last Update Submit

December 3, 2024

Conditions

Keywords

PediatricClinical researchApp

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of app-based consent versus paper-based consent

    To determine better or similar comprehension of study requirements, risks and benefits, as measured by a comprehension questionnaire, and better or similar family preference for this mode of consenting. Scored using a 5-item custom multiple-choice test, with higher scores being better.

    Immediately after consent is given for the study

Secondary Outcomes (1)

  • Trust in the research consent process when using app-based consent versus paper-based consent

    Immediately after consent is given for the study

Study Arms (2)

App-based consent

EXPERIMENTAL

Prototype consent app based on REDCap eConsent module

Device: Consent App

Traditional paper-based consent

ACTIVE COMPARATOR

Traditional paper-based consent

Other: Traditional paper-based consent

Interventions

Family will receive their study information and consent form in an app on a tablet

App-based consent

Patient/family will receive their study information and consent on a traditional paper form

Traditional paper-based consent

Eligibility Criteria

Age2 Years - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children between the ages of 2 to 5 years who need an IV insertion in the medical imaging department.

You may not qualify if:

  • Children who are nonverbal;
  • Children with existing vascular access
  • Families who choose not to have topical anesthetic placed on their child's hands
  • Children receiving anxiolytic premedication
  • Children planned to undergo mask induction of anesthesia before IV placement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BC Children ' s Hospital

Vancouver, British Columbia, V6H 3N1, Canada

Location

Related Publications (7)

  • Lalloo C, Pham Q, Cafazzo J, Stephenson E, Stinson J. A ResearchKit app to deliver paediatric electronic consent: Protocol of an observational study in adolescents with arthritis. Contemp Clin Trials Commun. 2020 Jan 14;17:100525. doi: 10.1016/j.conctc.2020.100525. eCollection 2020 Mar.

    PMID: 32211557BACKGROUND
  • Blake K, Holbrook JT, Antal H, Shade D, Bunnell HT, McCahan SM, Wise RA, Pennington C, Garfinkel P, Wysocki T. Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: Study design and rationale. Contemp Clin Trials. 2015 May;42:105-18. doi: 10.1016/j.cct.2015.03.012. Epub 2015 Apr 3.

    PMID: 25847579BACKGROUND
  • Seltzer E, Goldshear J, Guntuku SC, Grande D, Asch DA, Klinger EV, Merchant RM. Patients' willingness to share digital health and non-health data for research: a cross-sectional study. BMC Med Inform Decis Mak. 2019 Aug 8;19(1):157. doi: 10.1186/s12911-019-0886-9.

    PMID: 31395102BACKGROUND
  • Adjekum A, Blasimme A, Vayena E. Elements of Trust in Digital Health Systems: Scoping Review. J Med Internet Res. 2018 Dec 13;20(12):e11254. doi: 10.2196/11254.

    PMID: 30545807BACKGROUND
  • Miller CK, O'Donnell DC, Searight HR, Barbarash RA. The Deaconess Informed Consent Comprehension Test: an assessment tool for clinical research subjects. Pharmacotherapy. 1996 Sep-Oct;16(5):872-8.

    PMID: 8888082BACKGROUND
  • Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst. 2001 Jan 17;93(2):139-47. doi: 10.1093/jnci/93.2.139.

    PMID: 11208884BACKGROUND
  • Sugarman J, Lavori PW, Boeger M, Cain C, Edsond R, Morrison V, Yeh SS. Evaluating the quality of informed consent. Clin Trials. 2005;2(1):34-41. doi: 10.1191/1740774505cn066oa.

    PMID: 16279577BACKGROUND

Related Links

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Matthias Görges, PhD

    The University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
As blinding is impossible, we will not conceal allocation from any members of the clinical or study teams.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Open Label Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor (Partner)

Study Record Dates

First Submitted

May 10, 2023

First Posted

May 30, 2023

Study Start

July 27, 2023

Primary Completion

July 24, 2024

Study Completion

July 24, 2024

Last Updated

December 5, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Results will be presented at scientific conferences and published in peer-reviewed anesthesia journals. Once data collection is complete, a de-identified version of the data may be made available to other researchers. This is stated explicitly in the consent form, and participants are notified during the consent process that their de-identified data may be released to others for research purposes.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Once data collection is complete, de-identified data will be deposited in the University of British Columbia (UBC)'s Dataverse Repository. The study teams will keep research data for five years post-publication, as outlined in the UBC study data retention guidelines, after which it will be destroyed.
Access Criteria
Details have yet to be determined.

Locations